% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
%
\documentclass[
  ignorenonframetext,
]{beamer}
\usepackage{pgfpages}
\setbeamertemplate{caption}[numbered]
\setbeamertemplate{caption label separator}{: }
\setbeamercolor{caption name}{fg=normal text.fg}
\beamertemplatenavigationsymbolsempty
% Prevent slide breaks in the middle of a paragraph
\widowpenalties 1 10000
\raggedbottom
\setbeamertemplate{part page}{
  \centering
  \begin{beamercolorbox}[sep=16pt,center]{part title}
    \usebeamerfont{part title}\insertpart\par
  \end{beamercolorbox}
}
\setbeamertemplate{section page}{
  \centering
  \begin{beamercolorbox}[sep=12pt,center]{part title}
    \usebeamerfont{section title}\insertsection\par
  \end{beamercolorbox}
}
\setbeamertemplate{subsection page}{
  \centering
  \begin{beamercolorbox}[sep=8pt,center]{part title}
    \usebeamerfont{subsection title}\insertsubsection\par
  \end{beamercolorbox}
}
\AtBeginPart{
  \frame{\partpage}
}
\AtBeginSection{
  \ifbibliography
  \else
    \frame{\sectionpage}
  \fi
}
\AtBeginSubsection{
  \frame{\subsectionpage}
}
\usepackage{amsmath,amssymb}
\usepackage{lmodern}
\usepackage{iftex}
\ifPDFTeX
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math}
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\newif\ifbibliography
\usepackage{longtable,booktabs,array}
\usepackage{calc} % for calculating minipage widths
\usepackage{caption}
% Make caption package work with longtable
\makeatletter
\def\fnum@table{\tablename~\thetable}
\makeatother
\usepackage{graphicx}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother
\setlength{\emergencystretch}{3em} % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{-\maxdimen} % remove section numbering
\ifLuaTeX
  \usepackage{selnolig}  % disable illegal ligatures
\fi
\IfFileExists{bookmark.sty}{\usepackage{bookmark}}{\usepackage{hyperref}}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\urlstyle{same} % disable monospaced font for URLs
\hypersetup{
  pdftitle={血液系统肿瘤},
  pdfauthor={fallingstar},
  hidelinks,
  pdfcreator={LaTeX via pandoc}}

\title{血液系统肿瘤}
\author{fallingstar}
\date{2022-08-09}

\begin{document}
\frame{\titlepage}

\begin{frame}{伊甸园：创造与源起}
\protect\hypertarget{ux4f0aux7538ux56edux521bux9020ux4e0eux6e90ux8d77}{}
\begin{itemize}
\item
  The lymphatic system begins to develop at the end of the sixth week
\item
  originally from primordial stem cells in the umbilical vesicle
  mesenchyme and later from the liver and spleen.
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{正常白细胞的组成成分}
\protect\hypertarget{ux6b63ux5e38ux767dux7ec6ux80deux7684ux7ec4ux6210ux6210ux5206}{}
Of the total WBCs, the normal percentages of the different types are
approximately the following:

• Neutrophils: 62.0\%

• Eosinophils:2.3\%

• Basophils:0.4\%

• Monocytes: 5.3\%

• Lymphocytes:30.0\%
\end{block}
\end{frame}

\begin{frame}
\begin{block}{正常白细胞的重要特征}
\protect\hypertarget{ux6b63ux5e38ux767dux7ec6ux80deux7684ux91cdux8981ux7279ux5f81}{}
\begin{itemize}
\item
  髓系白细胞 核形态与HE染色形态
\item
  淋系白细胞 细胞表面CD分子
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{compared between mature B \& T cells}
\protect\hypertarget{compared-between-mature-b-t-cells}{}
\begin{columns}[T]
\begin{column}{0.5\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208011514652.png}

\begin{itemize}
\item
  PLUS Ig protein
\item
  class switch
\item
  B = bone marrow.
\end{itemize}
\end{column}

\begin{column}{0.5\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208011514660.png}

\begin{itemize}
\tightlist
\item
  cytotoxic T CD8 with MHC I \& helper T CD4 with MHC 2
\end{itemize}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{血细胞分化过程(概况)}
\protect\hypertarget{ux8840ux7ec6ux80deux5206ux5316ux8fc7ux7a0bux6982ux51b5}{}
\begin{columns}[T]
\begin{column}{0.4\textwidth}
\begin{itemize}
\item
  multipotential stem cells(MHSC) \%\textgreater\% committed stem
  cells(CFU/LSC) \%\textgreater\% mature WBC
\item
  growth inducers -\textgreater{} CFU/LSC ;e.g.~IL-3 \# promote growth
\item
  differentiation inducers
\end{itemize}
\end{column}

\begin{column}{0.6\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208011514656.png}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{血细胞分化过程（髓系）}
\protect\hypertarget{ux8840ux7ec6ux80deux5206ux5316ux8fc7ux7a0bux9ad3ux7cfb}{}
\begin{columns}[T]
\begin{column}{0.4\textwidth}
\begin{itemize}
\item
  formed \& stored in the bone marrow
\item
  three times (6 days' supply)
\end{itemize}
\end{column}

\begin{column}{0.6\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208011514655.png}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{血细胞分化过程（淋系）}
\protect\hypertarget{ux8840ux7ec6ux80deux5206ux5316ux8fc7ux7a0bux6dcbux7cfb}{}
\begin{columns}[T]
\begin{column}{0.4\textwidth}
\begin{itemize}
\item
  produced mainly in the various lymphogenous tissues
\item
  mostly stored in the various lymphoid tissues, except for a small
  number that are temporarily being transported in the blood.
\end{itemize}
\end{column}

\begin{column}{0.6\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208011514659.png}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{B细胞的分化（补充）}
\protect\hypertarget{bux7ec6ux80deux7684ux5206ux5316ux8865ux5145}{}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208051239738.png}
\end{block}
\end{frame}

\begin{frame}{失乐园：血细胞癌变}
\protect\hypertarget{ux5931ux4e50ux56edux8840ux7ec6ux80deux764cux53d8}{}
\begin{itemize}
\tightlist
\item
  常见基因突变与通路
\item
  幼稚细胞代谢与酶
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{常见基因突变与通路}
\protect\hypertarget{ux5e38ux89c1ux57faux56e0ux7a81ux53d8ux4e0eux901aux8def}{}
\begin{enumerate}
\item
  tyrosine kinase activity
\item
  RAS signaling
\item
  围绕14号染色体IgH的融合
\item
  特定重要分化因子的阻断
\item
  其他
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{tyrosine kinase activity}
\protect\hypertarget{tyrosine-kinase-activity}{}
\begin{columns}[T]
\begin{column}{0.4\textwidth}
\begin{itemize}
\item
  ABL and BCR (9;22) translocation
\item
  JAK2
\item
  MYD88
\item
  BTK
\end{itemize}
\end{column}

\begin{column}{0.6\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071534100.svg}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{figure}
\centering
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071636471.png}
\caption{布鲁顿酪氨酸激酶（BTK）是B细胞抗原受体和细胞因子受体途径的信号分子。这种BTK信号传导会激活B细胞增殖，运输，趋化性和粘附所必需的途径}
\end{figure}
\end{frame}

\begin{frame}
\begin{block}{RAS signaling \&\& chromosome 14}
\protect\hypertarget{ras-signaling-chromosome-14}{}
\begin{columns}[T]
\begin{column}{0.4\textwidth}
\begin{itemize}
\item
  MYC with 14
\item
  BCL2
\item
  cyclin D1/cyclin D3
\item
  PTEN
\item
  CDKN2A
\item
  acquired mutation in the serine/threonine kinase BRAF, that leads to
  hyperactivityof the kinase
\end{itemize}
\end{column}

\begin{column}{0.6\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071543228.svg}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071637147.png}
\end{frame}

\begin{frame}
\begin{block}{特定重要分化因子的阻断}
\protect\hypertarget{ux7279ux5b9aux91cdux8981ux5206ux5316ux56e0ux5b50ux7684ux963bux65ad}{}
\begin{itemize}
\item
  NOTCH1, a gene that is essential for T cell differentiation
\item
  PAX5，a genes that are required for B cell differentiation
\item
  PML/RARA fusion protein that blocks myeloid differentiation at the
  promyelocytic stage (15;17) translocation
\item
  mutations in isocitrate dehydrogenase (IDH). In such tumors, an
  ``oncometabolite''synthesized by the mutated IDH protein blocks the
  function of enzymes that regulate the epigenome and interferes with
  myeloid cell differentiation
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{其他：转录因子}
\protect\hypertarget{ux5176ux4ed6ux8f6cux5f55ux56e0ux5b50}{}
\begin{itemize}
\item
  BCL6 gene, located on 3q27
\item
  a (12;21) translocation involving the ETV6 and RUNX1 genes, creating a
  fusion gene encoding an aberrant transcription factor
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{特征酶与代谢}
\protect\hypertarget{ux7279ux5f81ux9176ux4e0eux4ee3ux8c22}{}
\begin{itemize}
\item
  TdT+ an enzyme specifically expressed in pre--B and pre--T cells
\item
  MPO
\item
  LAP
\item
  PAS染色
\item
  TRAP染色
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{末端脱氧核苷酸转移酶（Terminal deoxynucleotidyl
transferase，TdT）}
\protect\hypertarget{ux672bux7aefux8131ux6c27ux6838ux82f7ux9178ux8f6cux79fbux9176terminal-deoxynucleotidyl-transferasetdt}{}
tdt是一种特殊的DNA聚合酶，显示出未成熟的、``前B''，``前T淋巴细胞''和''急性淋巴性白血病/淋巴瘤细胞''。``末端转移酶''于''抗体基因重组时''加上N核苷酸至V(D)J的外显子上，能够形成连接多样性现象。

在免疫组织化学中，抗体TdT酶可用于显示未成熟的T细胞和B细胞以及多能的''造血干细胞''的存在，其具有抗原，而成熟的淋巴样细胞总是呈''TdT阴性''。而末端转移酶阳性的细胞中发现少量的健康淋巴结和扁桃体，急性淋巴细胞白血病的恶性细胞也呈''TdT阳性''
\end{block}
\end{frame}

\begin{frame}
\begin{block}{髓过氧化物酶（Myeloperoxidase，MPO）}
\protect\hypertarget{ux9ad3ux8fc7ux6c27ux5316ux7269ux9176myeloperoxidasempo}{}
MPO是一种由人类17号染色体上\_MPO\_基因编码的过氧化物酶。MPO主要表达于中性粒细胞（白细胞中，并产生次卤酸，发挥其抗菌活性。髓过氧化物酶是中性粒细胞嗜天青颗粒中的一种溶酶体蛋白，在脱颗粒的时候释放到胞外。MPO内含有一个血红素组分，使得富含中性粒细胞的分泌物显示出绿色，这些分泌物包括脓和黏液
\end{block}
\end{frame}

\begin{frame}
\begin{block}{白细胞碱性磷酸酶（LAP）}
\protect\hypertarget{ux767dux7ec6ux80deux78b1ux6027ux78f7ux9178ux9176lap}{}
人血液和造血细胞的碱性磷酸酶pH值为9.4，主要见于中性粒细胞系的成熟阶段或晚幼粒细胞。在不同生理状态和病理状态中均有明显的改变

\begin{itemize}
\tightlist
\item
  白细胞碱性磷酸酶积分
\end{itemize}

ALP活性仅见于成熟或接近成熟的中性粒细胞。计数100个中性粒细胞中阳性细胞数，按阳性细胞中的颗粒密度分为1～5级，指数各为1～5。计算100个中性粒细胞，将每个细胞的指数相加，其总和称阳性指数或积分
\end{block}
\end{frame}

\begin{frame}
\begin{block}{PAS染色}
\protect\hypertarget{pasux67d3ux8272}{}
又称过碘酸雪夫染色，糖原染色。一般用来显示糖元和其它\[多糖\]物质。

\[阳性\]反应，胞浆呈红色，阴性反应，胞浆呈无色；在正常血片中RBC不染色；PLT染成深红色；\[中性粒细胞\]胞浆染成红色或深红色，有些细胞有阳性颗粒；\[单核细胞\]的胞浆染成淡红色，可含有细小或粗大阳性颗粒；少数\[淋巴细胞\]的胞浆内含有少许小的淡红色或红色颗粒；正常骨髓的\[幼稚细胞\]都不染色；\[巨核细胞\]的胞浆内呈弥散红色或深红色。巨核细胞的胞浆内呈弥散红色或深红色。
\end{block}
\end{frame}

\begin{frame}{复乐园：抗肿瘤药物的常见类型与机理}
\protect\hypertarget{ux590dux4e50ux56edux6297ux80bfux7624ux836fux7269ux7684ux5e38ux89c1ux7c7bux578bux4e0eux673aux7406}{}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071658698.png}
\end{frame}

\begin{frame}
\begin{block}{Antitumor antibiotics 抗肿瘤抗生素}
\protect\hypertarget{antitumor-antibiotics-ux6297ux80bfux7624ux6297ux751fux7d20}{}
\begin{quote}
All are cell cycle nonspecific, except bleomycin which is G2/M phase
specific.
\end{quote}

\begin{itemize}
\item
  bleomycin博来霉素 breaks in DNA strands
\item
  doxorubicin阿霉素 topoisomerase II -\textgreater{} 抑制复制
\item
  daunorubicin柔毛霉素 同上
\item
  idarubicin柔红酶素 同上
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{去甲基化药物}
\protect\hypertarget{ux53bbux7532ux57faux5316ux836fux7269}{}
\begin{itemize}
\item
  azecitidine 氮杂胞嘧啶核苷
\item
  decitabine地西他滨
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Antimetabolites 抗代谢药物}
\protect\hypertarget{antimetabolites-ux6297ux4ee3ux8c22ux836fux7269}{}
\begin{quote}
All are S-phase specific except cladribine, which is cell cycle
nonspecific.
\end{quote}

\begin{itemize}
\item
  Cladribine.克拉屈滨 嘌呤类似物
\item
  fludarabine氟达拉滨 同上
\item
  pentostatin喷司他丁 同上
\item
  dacarbazine 氮烯唑胺 同上
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{quote}
接上页
\end{quote}

\begin{itemize}
\item
  cytarabine阿糖胞苷 嘧啶类似物
\item
  hydroxyurea羟基脲 抑制核糖核苷酸还原酶
\item
  methotrexate~甲氨蝶呤 叶酸类似物
\item
  asparaginase门冬氨酰酶 门冬酰胺水解，使肿瘤细胞缺乏门冬酰胺，抑制生长
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{激素类}
\protect\hypertarget{ux6fc0ux7d20ux7c7b}{}
\begin{quote}
糖皮质激素抑制细胞摄取糖、氨基酸和核苷，抑制大分子物质合成，导致细胞生长增殖停滞，继之染色质凝集、DNA断裂，最终致使细胞裂解
\end{quote}

\begin{itemize}
\item
  dexamethasone 地塞米松
\item
  prednisone强的松
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Alkylatingagents 烷基化药物}
\protect\hypertarget{alkylatingagents-ux70f7ux57faux5316ux836fux7269}{}
\begin{quote}
All are cell cycle nonspecific.
\end{quote}

\begin{quote}
类似地，作用于DNA双链连接
\end{quote}

\begin{itemize}
\item
  chlorambucil 苯丁酸氮芥
\item
  cyclophosphamide 环磷酰胺
\item
  melphalan 美法兰
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Microtubule inhibitors}
\protect\hypertarget{microtubule-inhibitors}{}
\begin{quote}
All are M-phase specific.
\end{quote}

\begin{itemize}
\item
  vincristine长春新碱 纺锤丝形成抑制
\item
  vinblastine长春碱
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{肿瘤单抗与分子抑制剂}
\protect\hypertarget{ux80bfux7624ux5355ux6297ux4e0eux5206ux5b50ux6291ux5236ux5242}{}
\begin{itemize}
\item
  rituximab利妥昔单抗 CD20
\item
  tyrosine kinase inhibitors (eg, imatinib伊马替尼)；
\item
  second-generation tyrosine kinase inhibitors (eg, dasatinib达沙替尼,
  nilotinib尼罗替尼)
\end{itemize}

\begin{quote}
格列卫
\end{quote}

\begin{itemize}
\tightlist
\item
  btk inhibitors ibrutinib通常被认为是一流的BTK抑制剂，而acalabrutinib
  被认为是第二代BTK抑制剂，主要是因为它表现出更高的选择性和对BTK靶向活性的抑制作用
\end{itemize}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 0\tabcolsep) * \real{0.0556}}@{}}
\toprule()
\endhead
\#\#\#\# compare btw first gen and second gen \\
- 伊马替尼 与 ABL 激酶的 ATP 结合位点结合产生抑制作用，对于野生型的
BCR-ABL 激酶的作用效果良好，而对突变型的效果不佳。 - 第 2
代药物对于野生型及绝大部分突变型的 BCR-ABL激酶都有更好的抑制作用，
但对于 T315I 突变型效果较差。 - 达沙替尼能够有效地抑制除T315I
的所有突变型 -
尼洛替尼对野生型BCR-ABL激酶非活化构象的亲和性明显高于伊马替尼，其对于BCR-ABL的各类突变型有良好的抑制效果，但对于
T315I无效。 \\
\bottomrule()
\end{longtable}
\end{block}

\begin{block}{特殊介绍 Bortezomib 硼替佐米}
\protect\hypertarget{ux7279ux6b8aux4ecbux7ecd-bortezomib-ux787cux66ffux4f50ux7c73}{}
\begin{itemize}
\item
  第一种可逆性和选择性的蛋白酶体 (**proteasome**) 抑制剂
\item
  靶向苏氨酸残基有效抑制 20S 蛋白酶体
\item
  破坏细胞周期、诱导细胞凋亡以及抑制核因子~**NF-κB**。
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{特殊介绍 lenalidomide来那度胺}
\protect\hypertarget{ux7279ux6b8aux4ecbux7ecd-lenalidomideux6765ux90a3ux5ea6ux80fa}{}
\begin{itemize}
\item
  一种泛素 E3 连接酶 cereblon (CRBN) 的配体
\item
  可通过 CRBN-CRL4 泛素连接酶对两种淋巴转录因子 IKZF1 和 IKZF3
  进行选择性泛素化和降解。
\item
  导致直接细胞毒作用和免疫调节作用：增加T细胞和自然杀伤细胞的数量和活性
\item
  特别地抑制成熟 B 细胞淋巴瘤 (包括多发性骨髓瘤) 的生长，并诱导 T
  细胞释放白细胞介素-2 (IL-2)。
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{并发症治疗：肿瘤溶解综合症}
\protect\hypertarget{ux5e76ux53d1ux75c7ux6cbbux7597ux80bfux7624ux6eb6ux89e3ux7efcux5408ux75c7}{}
\begin{itemize}
\item
  水化补液
\item
  allopurinol 别嘌呤醇
\item
  rasburicase拉布立酶 (often used in the pediatric population) to
  decrease serum uric acid as renal protection. Rasburicase is
  contraindicated in G6PD deficiency.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{并发症治疗：白细胞粘滞症}
\protect\hypertarget{ux5e76ux53d1ux75c7ux6cbbux7597ux767dux7ec6ux80deux7c98ux6edeux75c7}{}
\begin{itemize}
\tightlist
\item
  hydroxyurea 羟基脲
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{造血干细胞移植}
\protect\hypertarget{ux9020ux8840ux5e72ux7ec6ux80deux79fbux690d}{}
\begin{itemize}
\item
  血细胞来源
\item
  处理流程
\item
  术后白细胞复苏
\item
  并发症
\end{itemize}
\end{block}
\end{frame}

\begin{frame}{在人间：血液系统肿瘤概论}
\protect\hypertarget{ux5728ux4ebaux95f4ux8840ux6db2ux7cfbux7edfux80bfux7624ux6982ux8bba}{}
\begin{columns}[T]
\begin{column}{0.3\textwidth}
\begin{block}{LEUKOPENIA}
\protect\hypertarget{leukopenia}{}
\begin{itemize}
\item
  Within 2 days after the bone marrow stops producing WBCs, ulcers may
  appear in the mouth and colon, or some form of severe respiratory
  infection might develop.
\item
  Bacteria from the ulcers rapidly invade surrounding tissues and the
  blood. Without treatment, death often ensues in less than 1 week after
  acute total leukopenia begins.
\end{itemize}
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{block}{LEUKEMIAS}
\protect\hypertarget{leukemias}{}
\begin{itemize}
\item
  Uncontrolled production of WBCs \textless- cancerous mutation of a
  myelogenous or lymphogenous cell.
\item
  characterized by greatly increased numbers of abnormal WBCs in the
  circulating blood.
\end{itemize}
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{block}{Lymphoma}
\protect\hypertarget{lymphoma}{}
\begin{itemize}
\item
  Hodgkin lymphoma
\item
  none-Hodgkin lymphoma
\end{itemize}
\end{block}
\end{column}
\end{columns}
\end{frame}

\begin{frame}
\begin{block}{诊断：一些需要注意的问题}
\protect\hypertarget{ux8bcaux65adux4e00ux4e9bux9700ux8981ux6ce8ux610fux7684ux95eeux9898}{}
\begin{itemize}
\item
  WHO has formulated a widely accepted classification scheme for
  lymphoid neoplasms and myeloid neoplasms that relies on a combination
  of morphologic, phenotypic, genotypic, and clinical features.
\item
  B and T cell tumors often are composed of cells that are arrested at
  or derived from a specific stage of normal lymphocyte differentiation
\end{itemize}

\begin{quote}
acute= early phase chronic = maturation
\end{quote}

\begin{itemize}
\tightlist
\item
  diagnosis and classification rely heavily on tests (either
  immunohistochemistry or flow cytometry) that detect lineage-specific
  antigens (e.g., B cell, T cell, and NK cell markers) and markers of
  maturity
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{病程：一些需要注意的问题}
\protect\hypertarget{ux75c5ux7a0bux4e00ux4e9bux9700ux8981ux6ce8ux610fux7684ux95eeux9898}{}
\begin{itemize}
\item
  疾病转型 Class switching and somatic hypermutation are mistake-prone
  forms of regulated genomic instability that place germinal center B
  cells at relatively high risk for potentially transforming mutations
\item
  免疫异常 Lymphoid neoplasms often disrupt normal immune function. Both
  immunodeficiency (made evident by increased susceptibility to
  infection) and autoimmunity
\item
  用药与耐药突变
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{流行病学： 一些有趣的视角}
\protect\hypertarget{ux6d41ux884cux75c5ux5b66-ux4e00ux4e9bux6709ux8da3ux7684ux89c6ux89d2}{}
\begin{itemize}
\item
  病毒 ：EBV，HHV-8，HLTV
\item
  年龄： Overall, leukemia is more common in adults than children.
\item
  Newborn (NB) to 14 years of age

  • Acute lymphoblastic leukemia (ALL) most common overall cancer in
  children.
\item
  Persons 40 to 60 years of age

  Acute myelogenous leukemia (AML)

  Chronic myelogenous leukemia (CML)
\item
  Persons \textgreater60 years of age

  CLL most common type

  CML
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Acute and Chronic Leukemias 急性与慢性白血病}
\protect\hypertarget{acute-and-chronic-leukemias-ux6025ux6027ux4e0eux6162ux6027ux767dux8840ux75c5}{}
\begin{itemize}
\item
  Definition: Refers to malignant malignant diseases arising from bone
  marrow stem cells
\item
  secondary to a block in stem cell differentiation,leads to a
  monoclonal proliferation
\item
  Acute leukemia: Block occurs at an early stage of stem cell
  development.
\item
  Chronic leukemia: Block occurs at a later stage in stem cell
  development.（Some evidence of maturation）
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{急性白血病}
\protect\hypertarget{ux6025ux6027ux767dux8840ux75c5}{}
\begin{itemize}
\item
  三系减少 贫血（疲劳，苍白） （成熟）
  白细胞减少/免疫低下（感染发热）血小板减少（出血）
\item
  hypercellular BM with \textgreater20\% blast cells -》BM is usually
  replaced by blast cells -》PB present
\item
  normocytic to macrocytic anemia：叶酸的代谢
\end{itemize}

• WBC Count ranges from \textless10,000 cells/mm3 (normal) to
\textgreater100,000 cells/mm3.
\end{block}
\end{frame}

\begin{frame}
\begin{itemize}
\item
  肝脾肿大
\item
  无痛性淋巴结肿大
\item
  神经系统、睾丸累及（ALL,血X屏障),皮肤累及（T细胞）
\item
  骨痛
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{白细胞计数与白细胞}
\protect\hypertarget{ux767dux7ec6ux80deux8ba1ux6570ux4e0eux767dux7ec6ux80de}{}
\begin{itemize}
\item
  WBC count can be elevated, but the cells are dysfunctional
\item
  and patients may be neutropenic with a history of frequent infection.
\item
  risk for leukostasis count is very high (\textgreater{} 150,000/mm3 in
  AML, \textgreater{} 400,000/mm 3 in ALL
\end{itemize}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 0\tabcolsep) * \real{0.0556}}@{}}
\toprule()
\endhead
\#\#\#\#\# 白细胞粘滞症 \\
blasts occluding the microcirculation, leading to pulmonary edema, CNS
symptoms, ischemic injury, and DIC \\
\bottomrule()
\end{longtable}
\end{block}

\begin{block}{Diagnosis}
\protect\hypertarget{diagnosis}{}
■ Best initial test: CBC with smear showing blast cells.

■ Most accurate test: Bone marrow biopsy with flow cytometry to classify

leukemia type.
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597}{}
■ chemotherapy. bone marrow transplantation.

■ All-trans-retinoic acid (ATRA) is highly effective in APL.

■prevent tumor lysis syndrome (hyperuricemia, hyperkalemia, hypocal-

cemia, renal insufficiency, as blasts are destroyed by chemotherapy),

patients should be well hydrated. allopurinol or rasburicase to decrease
serum uric acid as renal protection. Rasburicase is con- traindicated in
G6PD deficiency.

■ 白细胞粘滞症
\end{block}
\end{frame}

\begin{frame}
\begin{block}{肿瘤溶解综合症}
\protect\hypertarget{ux80bfux7624ux6eb6ux89e3ux7efcux5408ux75c7}{}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071646303.png}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{慢性白血病}
\protect\hypertarget{ux6162ux6027ux767dux8840ux75c5}{}
• an insidious onset of signs and symptoms such ashepatosplenomegaly and
generalized painless lymphadenopathy.

\begin{itemize}
\item
  Blast cells in the PB are usually \textless10\% of the total WBC
  count.
\item
  Hypercellular BM with \textless10\% blast cells.
\item
  Leukemic cells show evidence of maturation.
\item
  ormocytic to macrocytic anemia
\item
  血小板减少
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Neoplastic Myeloid Disorders}
\protect\hypertarget{neoplastic-myeloid-disorders}{}
Disorders of the myeloid lineage include:

\begin{enumerate}
\item
  chronic myeloproliferative disorders.
\item
  myelodysplastic syndrome (MDS).
\item
  AML.
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{chronic myeloproliferative disorders 慢性骨髓增生性疾病}
\protect\hypertarget{chronic-myeloproliferative-disorders-ux6162ux6027ux9aa8ux9ad3ux589eux751fux6027ux75beux75c5}{}
\begin{enumerate}
[a.]
\item
  Polycythemia vera (most common)
\item
  CML
\item
  Primary myelofibrosis (PM)
\item
  Essential thrombocythemia
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Characteristics}
\protect\hypertarget{characteristics}{}
\begin{enumerate}
\item
  splenomegaly
\item
  propensity for reactive BM fibrosis (occurs in the ``spent phase'')
\item
  propensity for transformation to acute leukemia
\item
  JAK2 mutaion/费城染色体
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Polycythemia 红细胞增多症}
\protect\hypertarget{polycythemia-ux7ea2ux7ec6ux80deux589eux591aux75c7}{}
\begin{itemize}
\tightlist
\item
  Definition: Refers to an increase in hemoglobin (Hb), hematocrit
  (Hct), and
\end{itemize}

RBC count

\begin{itemize}
\item
  假性 vs 真性
\item
  malignant inappropriate absolute polycythemia
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{基因与后果}
\protect\hypertarget{ux57faux56e0ux4e0eux540eux679c}{}
\begin{itemize}
\item
  mutation of the JAK2 gene on the short arm of chromosome 9.
\item
  the signaling pathways that instructs the BM to generate hematopoietic
  cells.
\item
  Increased production of RBCs, granulocytes (neutrophils, eosinophils,
  basophils),mast cells, and platelets
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0}{}
\end{block}

\begin{columns}[T]
\begin{column}{0.3\textwidth}
\begin{block}{造血与代谢}
\protect\hypertarget{ux9020ux8840ux4e0eux4ee3ux8c22}{}
\begin{itemize}
\item
  splenomegaly (abdominal discomfort; \textgreater75\%).
\item
  gout.
\end{itemize}
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{block}{血小板与高粘滞血症}
\protect\hypertarget{ux8840ux5c0fux677fux4e0eux9ad8ux7c98ux6edeux8840ux75c7}{}
\begin{itemize}
\tightlist
\item
  ruddy (plethoric) face and prominence of the conjunctival and retinal
  vessels caused
\end{itemize}

by congestion (Link 13-9).

\begin{itemize}
\item
  bleeding (e.g., epistaxis \[nose bleed\]).
\item
  高粘滞血症、血栓形成

  \begin{enumerate}
  [(a)]
  \item
    Hyperviscosity (decreased circulation in vessels) is related to the
    increased RBC count or mass
  \item
    Sites of thrombosis include the hepatic vein, portal vein, dural
    sinus, and retinal veins. -\textgreater{} impaired CNS circulation
  \end{enumerate}
\end{itemize}
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{block}{肥大细胞增多}
\protect\hypertarget{ux80a5ux5927ux7ec6ux80deux589eux591a}{}
\begin{itemize}
\item
  signs of increased histamine released from mast cells:

  \begin{enumerate}
  [(a)]
  \item
    pruritus (itchiness) after bathing.
  \item
    peptic ulcer disease.
  \end{enumerate}
\end{itemize}
\end{block}
\end{column}
\end{columns}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-1}{}
\begin{itemize}
\tightlist
\item
  放血疗法 reduce hyperviscosity (reduces risk for thrombosis).
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Chronic myelogenous leukemia (CML) 慢性髓细胞白血病}
\protect\hypertarget{chronic-myelogenous-leukemia-cml-ux6162ux6027ux9ad3ux7ec6ux80deux767dux8840ux75c5}{}
\begin{itemize}
\item
  Definition: Refers to a malignant clonal stem cell disease of the
  pluripotential stem cell that is associated with the presence of the
  Philadelphia chromosome
\item
  BCR gene on chromosome 22 and the ABL gene on chromosome 9
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{基因与后果}
\protect\hypertarget{ux57faux56e0ux4e0eux540eux679c-1}{}
\begin{itemize}
\item
  The growth factor dependence of CML progenitors is greatly decreased
  by constitutive signals generated by BCR-ABL that mimic the effects of
  growth factor receptor activation.
\item
  Importantly, because BCR-ABL does not inhibit differentiation,the
  early disease course is marked by excessive production of relatively
  normal blood cells, particularly granulocytes and platelets
\item
  vs a lekemoid reaction：Basophilia \& leukocyte alkaline phosphatase
  (LAP)
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-1}{}
\end{block}

\begin{columns}[T]
\begin{column}{0.3\textwidth}
\begin{block}{分期}
\protect\hypertarget{ux5206ux671f}{}
\begin{itemize}
\tightlist
\item
  Three stages of CML:
\end{itemize}

■ Chronic: Without treatment, this phase typically lasts 3.5--5.0
years.asymptomatic.

■Accelerated: A transition toward blast crisis, with an ↑ in peripheral
and bone marrow blood counts. Should be suspected when the differential
shows an abrupt ↑ in basophils and thrombocytopenia (platelet count
\textless{} 100,000/mm3).

■ Blast crisis: A large percentage of untreated CML patients will
eventually reach this phase. Resembles acute leukemia; survival is 3--6
months..
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{block}{经典症状}
\protect\hypertarget{ux7ecfux5178ux75c7ux72b6}{}
\begin{enumerate}
\item
  外周白细胞增多 10,000 to 500,000 cells/mm3

  \(a\) Myeloid cells in all stages of development are seen (sign of
  maturation).

  \(b\) Basophilia (increased basophils in the PB) is a consistent
  finding.
\item
  骨髓高增生，myeloblasts account for \textless10\%
\item
  贫血
\item
  血小板减少
\end{enumerate}
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{block}{急变期 blast crisis}
\protect\hypertarget{ux6025ux53d8ux671f-blast-crisis}{}
\begin{itemize}
\item
  \begin{enumerate}
  [(a)]
  \tightlist
  \item
    Usually occurs in \textasciitilde5 years
  \end{enumerate}
\item
  \begin{enumerate}
  [(a)]
  \setcounter{enumi}{1}
  \tightlist
  \item
    Rapid increase in numbers of myeloblasts (70\%) or lymphoblasts
    (30\%)
  \end{enumerate}
\item
  \begin{enumerate}
  [(a)]
  \setcounter{enumi}{2}
  \tightlist
  \item
    No Auer rods are present in the myeloblasts (see later).
  \end{enumerate}
\end{itemize}
\end{block}
\end{column}
\end{columns}
\end{frame}

\begin{frame}
\begin{block}{Diagnosis}
\protect\hypertarget{diagnosis-1}{}
■ Most accurate test: Philadelphia chromosome via PCR or FISH analysis

showing the t(9,22) translocation, although some cases lack the
translocation.

■ CBC often shows a very high WBC count---often \textgreater{}
100,000/mm3
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-2}{}
■ Chronic: Treat with tyrosine kinase inhibitors (eg, imatinib). Young

patients may be candidates for allogeneic stem cell transplantation

■ Blast crisis: Same as that for acute leukemia, or second-generation
tyro-

sine kinase inhibitors (eg, dasatinib, nilotinib) plus hematopoietic
stem

cell transplantation or a clinical trial.
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Primary myelofibrosis 原发性骨髓纤维化}
\protect\hypertarget{primary-myelofibrosis-ux539fux53d1ux6027ux9aa8ux9ad3ux7ea4ux7ef4ux5316}{}
\begin{itemize}
\item
  \begin{enumerate}
  [a.]
  \tightlist
  \item
    Definition: Refers to a malignant clonal myeloproliferative disorder
    arising from the neoplastic transformation of early hematopoietic
    stem cells
  \end{enumerate}
\item
  Primarily occurs in those \textgreater50 years of age
\item
  most cases is caused by a mutation of the JAK2 gene
\item
  BM fibrosis occurs earlier than in the other chronic
  myeloproliferative diseases.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{基因与后果}
\protect\hypertarget{ux57faux56e0ux4e0eux540eux679c-2}{}
\begin{itemize}
\item
  Ineffective erythropoiesis is characterized by the presence of
  dysplastic megakaryocytes (abnormal appearing megakaryocytes),
  increased numbers of immature granulocytes (myeloblasts,
  promyelocytes, metamyelocytes), and an early onset of reactive
  myelofibrosis.
\item
  inappropriate release of fibrogenic factors from neoplastic
  megakaryocytes.

  platelet-derived growth factor and TGF-β are fibroblast mitogens.

  In addi-tion, TGF-β promotes collagen deposition and causes
  angiogenesis
\item
  BM fibrosis occurs earlier than in the other chronic
  myeloproliferative diseases.
\item
  leads to cytopenias and extensive extra-medullary
  hematopoiesishematopoiesis
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-2}{}
\begin{block}{血细胞减少}
\protect\hypertarget{ux8840ux7ec6ux80deux51cfux5c11}{}
\begin{itemize}
\item
  WBC count ranging from 10,000 to 50,000 cells/mm3.
\item
  normocytic anemia. Teardrop cells (damaged RBCs)
\item
  Leukoerythroblastosis
\item
  Platelets are morphologically abnormal.

  variable platelet count.
\end{itemize}
\end{block}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-3}{}
\begin{enumerate}
\item
  mild cases :support treatment
\item
  low-risk hydroxyurea
\item
  high-risk jak2 inhibitor ruxolitinib + lenalidomide
\item
  HCT
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Essential thrombocythemia}
\protect\hypertarget{essential-thrombocythemia}{}
\begin{itemize}
\item
  Definition: Refers to a malignant clonal myeloproliferative disease
  arising from pluripotential stem cells that leads to an increase in
  platelets
\item
  jak2
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-3}{}
\begin{columns}[T]
\begin{column}{0.3\textwidth}
\begin{block}{血细胞}
\protect\hypertarget{ux8840ux7ec6ux80de}{}
\begin{itemize}
\item
  thrombocytosis. \textgreater600,000 cells/mm3 (frequently
  \textgreater1 million cells/mm3) + Platelet morphology abnormal.
\item
  mild neutrophilic leukocytosis.
\item
  basophilia (increased numbers of basophils in the peripheral blood).
\item
  hypercellular BM with numerous megakaryocytes that appear abnormal
\end{itemize}
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{itemize}
\tightlist
\item
  bleeding caused by platelet dysfunction.
\end{itemize}

Usually the bleeding is gastrointestinal (GI) in origin;

\begin{itemize}
\item
  Vessel thrombosis may also occur.
\item
  splenomegaly.
\end{itemize}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-4}{}
oral hydroxyurea 羟基脲
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Myelodysplastic syndromes (MDS)}
\protect\hypertarget{myelodysplastic-syndromes-mds}{}
\begin{itemize}
\item
  Definition: Group of acquired clonal stem cell disorders that
  characteristically exhibit cytopenias despite a hypercellular BM
\item
  not yet full-understand
\item
  Cytogenetic abnormalities are present in 40\%--70\% of patients with
  primary MDS and in \textgreater90\% of those with treatment-related
  MDS.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{itemize}
\item
  Initial genetic event occurs association with inflammation and an
  increase in tumor necrosis factor-α (TNF-α) and interferon-γ (γ-IF).
\item
  transformed multipotent stem cell that retains the capacity to
  differentiate into red cells, granulocytes, and platelets, but in a
  manner that is both ineffective and disordered
\item
  In early stages of the MDS, apoptosis and increased cell proliferation
  prevail, leading to a hypercellular BM and PB cytopenias.
\item
  In later stages of MDS, apoptosis decreases, and proliferation
  increases.Clinically,the disease is more aggressive, and the risk for
  transformation into acute myelogenous leukemia (AML) increases.
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{Classification：？\% blasts in PB?BM?}
\protect\hypertarget{classification-blasts-in-pbbm}{}
\begin{itemize}
\item
  Refractory anemia (RA): cytopenia in the PB is present in only 1
  lineage; \textless1\% blasts are present in the PB, and \textless5\%
  blasts are present in the BM; normocellular to hypercellular BM.
\item
  RA with ringed sideroblasts (RARS): similar to RA; however, there are
  \textgreater15\% ringed sideroblasts in the BM
\item
  RA with excess blast cells (RAEB): Cytopenias are present in two or
  more lineages; \textless5\% blasts are present in the PB or 5\% to
  20\% blasts are present in the BM.
\item
  RA with excess blast cells in transformation (RAEB-t): same
  hematologic parameters as RAEB except there are \textgreater5\% blasts
  in the PB or 21\% to 30\% in the BM
\item
  Chronic myelomonocytic leukemia (CMML): Monocytosis is present in the
  PB; \textless5\% blasts are in the PB and up to 20\% BM blasts.
  Splenomegaly is usually present, unlike the other types of MDS.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-4}{}
\begin{columns}[T]
\begin{column}{0.3\textwidth}
\begin{block}{血细胞: severe pancytopenia}
\protect\hypertarget{ux8840ux7ec6ux80de-severe-pancytopenia}{}
\begin{itemize}
\item
  Macrocytic anemia RBCs are the first cell line affected.
\item
  Hypersegmented neutrophils , pseudo-Pelger Huet cells
\item
  Thrombocytopenia (platelets are the last lineage to be affected)
\end{itemize}
\end{block}
\end{column}

\begin{column}{0.3\textwidth}
\begin{block}{Bone marrow findings}
\protect\hypertarget{bone-marrow-findings}{}
\begin{itemize}
\item
  Ringed sideroblasts (nucleated RBCs with excess iron)
\item
  Number of myeloblasts varies with the type of MDS

  \begin{enumerate}
  [(a)]
  \item
    If myeloblasts are \textgreater30\%, it has progressed to AML.
  \item
    Dysplastic megakaryocytes are commonly present
  \end{enumerate}
\item
  Hypocellular MDS occurs in \textless20\% of cases, making it difficult
  to separate from aplastic anemia and PNH.
\end{itemize}
\end{block}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-5}{}
\begin{enumerate}
\item
  EPO
\item
  lenalidomide
\item
  azecitidine氮杂卓类/decitabine地西他滨
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Acute myelogenous leukemia (AML)}
\protect\hypertarget{acute-myelogenous-leukemia-aml}{}
\begin{itemize}
\item
  Definition: Refers to a malignancy of granulocyte progenitor cells
\item
  mutations in genes encoding transcription factors that are required
  for normal myeloid cell differentiation
\item
  PML/RARA fusion protein
\item
  MPO -\textgreater{} auer body
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{itemize}
\item
  FAB classification (mostly used in textbook)
\item
  WHO classification (new fashion)
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{WHO classification:molecular features.}
\protect\hypertarget{who-classificationmolecular-features.}{}
\begin{itemize}
\item
  AMLs associated with specific genetic aberrations, which are important
  because they predict outcome and they guide therapy;
\item
  AMLs with dysplasia, many of which arise from MDSs
\item
  AMLs occurring after genotoxic chemotherapy;
\item
  AMLs lacking any of the foregoing features.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{FAB classification}
\protect\hypertarget{fab-classification}{}
\begin{columns}[T]
\begin{column}{0.3\textwidth}
\begin{itemize}
\item
  based on cell type and differential
\item
  Auer rods are splinter-shaped to rod-shaped structures in the cytosol
  of myeloblasts

  \begin{enumerate}
  [(a)]
  \item
    Fused azurophilic granules
  \item
    Only present in the M2 and M3 subtypes
  \item
    Not present in myeloblasts in CML even when they transform into a
    blast crisis
  \end{enumerate}
\end{itemize}
\end{column}

\begin{column}{0.7\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208041620075.png}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-5}{}
\begin{enumerate}
\item
  Normocytic anemia fatigue
\item
  thrombocytopenia bleeding
\item
  leukocytosis WBC counts can be low or high. Hyperleukocytosis may also
  occur with WBC counts 100, 000 cells/mL.
\item
  fever (infection risk is increased).
\item
  splenomegaly and lymphadenopathy uncommon.
\item
  gum infiltration (common in acute monocytic leukemia \[M5\]).
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{AUER body奥氏小体}
\protect\hypertarget{auer-bodyux5965ux6c0fux5c0fux4f53}{}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071754106.png}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-6}{}
\begin{enumerate}
\item
  remission induction daunorubicin柔毛霉素/idarubicin柔红酶素(3days)
  +cytarabine阿糖胞苷 (7-10days)
\item
  consolidation
\item
  并发症处理:肿瘤溶解综合症、白细胞粘滞
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Lymphoid Leukemias}
\protect\hypertarget{lymphoid-leukemias}{}
\begin{itemize}
\item
  Acute lymphoblastic leukemia (ALL)
\item
  Adult T-cell leukemia
\item
  Chronic lymphoblastic leukemia (CLL)
\item
  hairy leukemia
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Acute lymphoblastic leukemia (ALL)}
\protect\hypertarget{acute-lymphoblastic-leukemia-all}{}
\begin{itemize}
\tightlist
\item
  Definition: Refers to an acute, rapidly progressive leukemia that is
  characterized by the presence of B or T lymphoblasts in the blood and
  bone marrow
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Immunologic classification}
\protect\hypertarget{immunologic-classification}{}
\end{block}

\begin{columns}[T]
\begin{column}{0.5\textwidth}
\begin{block}{early pre--B-cell ALL (80\% of cases)}
\protect\hypertarget{early-preb-cell-all-80-of-cases}{}
\begin{itemize}
\item
  common acute lymphocytic leukemia antigen (CALLA; CD10) are positive.
\item
  terminal deoxynucleotidyl transferase (TdT) are positive.
\item
  t(12;21) translocation offers a favorable prognosis.
\item
  More than 95\% with this subtype of ALL achieve complete remission.
\end{itemize}
\end{block}
\end{column}

\begin{column}{0.5\textwidth}
\begin{block}{pre--B-, B-, and T-cell ALL.}
\protect\hypertarget{preb--b--and-t-cell-all.}{}
\end{block}
\end{column}
\end{columns}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-6}{}
\begin{itemize}
\item
  Peripheral WBC(majority lymphoblasts\textgreater20\%) count ranges
  from 10,000 to 100,000cells/m3
\item
  Fever caused by infection or cytokine release (interleukin-1,TNF)
\item
  Normocytic anemia with thrombocytopenia
\item
  BM replaced by lymphoblasts
\item
  CNS involvement in all types (spinal fluid analysis is mandatory when
  first diagnosed).

  B-cell testicles.

  T-cell types anterior mediastinal mass or as an acute leukemia
\item
  Flow cytometry is used to distinguish ALL from AML.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-7}{}
\begin{itemize}
\item
  daunorubicin,vincristine,prednisone,and asparaginase天门冬酸酶
\item
  methotrexate~甲氨蝶呤 prevent CNS relapse
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Adult T-cell leukemia}
\protect\hypertarget{adult-t-cell-leukemia}{}
\begin{itemize}
\tightlist
\item
  Definition: Type of leukemia that is associated with the human T-cell
  lymphotropic virus type 1 that often presents as a malignant lymphoma
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{基因与结果}
\protect\hypertarget{ux57faux56e0ux4e0eux7ed3ux679c}{}
\begin{itemize}
\item
  Associated with the human T-cell lymphotropic virus type 1 (HTLV-1)
\item
  Activation of the TAX gene inhibits the p53 suppressor gene.
\item
  Neoplastic CD4 helper T cells undergo monoclonal proliferation.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-7}{}
\begin{itemize}
\item
  Hepatosplenomegaly and generalized painless lymphadenopathy are
  present.
\item
  Skin infiltration is a common finding in all T-cell malignancies.
\item
  Lytic bone lesions occur in acute T-cell leukemia.
\item
  Peripheral WBC(Numerous lymphoblasts; CD4 + tdt-) count ranges from
  10,000 to 50,000cells/mm3.
\item
  Normocytic anemia and thrombocytopenia
\item
  BM replaced by sheets of CD4 lymphoblasts.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{chronic lymphoblastic leukemia (CLL)}
\protect\hypertarget{chronic-lymphoblastic-leukemia-cll}{}
\begin{itemize}
\item
  Definition: Refers to a neoplastic disorder of virgin B cells
  expressing the CD20 and surface immunoglobulins. The tumor cells also
  express CD5. (B cells that cannot differentiate into plasma cells)
\item
  Etiology of CLL is unknown.
\item
  an indolent, slowly growing tumor
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-8}{}
\begin{itemize}
\item
  Splenomegaly and lymphadenopathy
\item
  autoimmune hemolytic anemia (AIHA) Warm (IgG) or cold (IgM)
\item
  Hypogammaglobulinemia -\textgreater{} Risk of infection is increased.
\item
  Peripheral WBC count ranges from 15,000 to 200,000 cells/mm3.

  \begin{enumerate}
  [a.]
  \setcounter{enumi}{1}
  \item
    Lymphoblasts are \textless10\%
  \item
    Neutropenia
  \item
    Numerous ``smudge'' cells (fragile leukemic cells) are noted in the
    PB
  \end{enumerate}
\item
  BM findings in CLL

  replaced by neoplastic B cells

  Lymphoblasts account for \textless10\%
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{stage}
\protect\hypertarget{stage}{}
\begin{enumerate}
\item
  lymphocytosis
\item
  lymphadenopathy
\item
  slenomegaly
\item
  anemia
\item
  thrombocytopenia
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Diagnosis}
\protect\hypertarget{diagnosis-2}{}
■ Best initial test: CBC with differential and smear showing mature
lympho-

cytosis (NK cells, T cells, or B cells \textgreater{} 5000/mm3) and
characteristic smudge

cells (fragile leukemia cells crushed by the slide). See Figure 2.7-15.

■ Most accurate test: Flow cytometry showing the CD5 marker on B cells

(normally found on T cells).

■ Bone marrow biopsy is rarely required for diagnosis but may provide
prog-

nostic information.
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-8}{}
\begin{enumerate}
\item
  早期、无症状：观察
\item
  高级别、高肿瘤负荷，反复感染，B症状：治疗
\item
  localized (stage 1 and 2):radiation
\item
  \textgreater{} stage 2 with symptom: chemotherapy

  younger : fludarabine氟达拉滨 +/- rituximab +/- cyclophosphamide

  older : chlorambucil 苯丁酸氮芥+ novel anti-CD20 antibody
\end{enumerate}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Hairy cell leukemia (HCL) 毛细胞}
\protect\hypertarget{hairy-cell-leukemia-hcl-ux6bdbux7ec6ux80de}{}
\begin{itemize}
\item
  Definition: Refers to a rare subtype of B-cell leukemia that is
  characteristically positive for the TRAP (tartrate-resistant acid
  phosphatase) stain
\item
  Hallmark of the disease in 100\% of cases is a BRAF V600E mutation.
\item
  Spleen is the primary site for proliferation of the neoplastic cells.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{itemize}
\item
  Splenomegaly (90\% of cases)
\item
  Autoimmune vasculitis and arthritis may occur.
\item
  Pancytopenia (decreased neutrophils, lymphocytes, and platelets)
\item
  Leukemic cells have hair-like projections
\item
  BM findings in hairy cell leukemia

  \begin{enumerate}
  [(1)]
  \item
    Packed with neoplastic cells
  \item
    Increased reticulin fibers
  \end{enumerate}
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{毛细胞 hairy cell}
\protect\hypertarget{ux6bdbux7ec6ux80de-hairy-cell}{}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071755103.png}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Diagnosis}
\protect\hypertarget{diagnosis-3}{}
■ Best initial test: CBC with smear showing pathognomonic ``hairy
cells''

(mononuclear cells with many cytoplasmic projections)

■ Most accurate test: Flow cytometry identifying the ``hairy cells.''
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-9}{}
\begin{itemize}
\item
  无症状时观察即可
\item
  一下症状时需治疗：三系减少，脾大，B症状
\end{itemize}

■ Best initial treatment: Cladribine.克拉屈滨

■ Alternative treatment options include pentostatin喷司他丁,
splenectomy, and IFN-α.
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Lymphoid Tissue Disorder}
\protect\hypertarget{lymphoid-tissue-disorder}{}
\begin{itemize}
\item
  Non-Hodgkin Lymphoma
\item
  Hodgkin Lymphoma,
\item
  Plasma Cell Dyscrasias Gammopathies)
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{structure of lymph node}
\protect\hypertarget{structure-of-lymph-node}{}
\begin{columns}[T]
\begin{column}{0.5\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208042135928.png}

\begin{itemize}
\item
  Locations of B cells

  \begin{enumerate}
  [a.]
  \item
    germinal follicles
  \item
    germinal center large B cell antigen-specific
  \item
    mantle zone small B lymphocytes
  \end{enumerate}
\end{itemize}
\end{column}

\begin{column}{0.5\textwidth}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208042135311.png}

\begin{itemize}
\item
  Locations of T cells

  \begin{enumerate}
  [a.]
  \tightlist
  \item
    paracortex (parafollicular)
  \end{enumerate}
\item
  Sinus histiocyte
\end{itemize}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208071649113.png}
\end{frame}

\begin{frame}
\begin{block}{Non-Hodgkin's lymphoma (NHL)}
\protect\hypertarget{non-hodgkins-lymphoma-nhl}{}
\begin{itemize}
\item
  Definition: Group of malignancies arising from cells of lymphocytic or
  histiocytic origin and thus typically originate within lymphoid tissue
  in which most often appear (e.g., lymph nodes, tonsils, thymus, or
  Peyer patches)
\item
  Mutation produces a block at a specific stage in the development of B
  or T cells.
\item
  firm consistency and are fused together . On cut section, ``fish
  flesh'' appearance.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{classification}
\protect\hypertarget{classification}{}
Classified into low- (indolent) and high-grade (aggressive) lymphomas

\begin{itemize}
\item
  Low-grade lymphomas include follicular lymphoma (grades 1 and 2),
  chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL),
  and most skin lymphomas.
\item
  High-grade lymphomas include follicular lymphomas (grade 3B), diffuse
  large-cell lymphoma, mediastinal large B-cell lymphoma, peripheral
  T-cell lymphoma, mantle cell lymphoma, Burkitt lymphoma, and acute
  lymphoblastic lymphoma/leukemia.
\item
  Diffuse large-cell lymphoma is the overall most common type of NHL
  (30\% of cases).The second most common type is follicular lymphoma
  (25\% of cases).
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{itemize}
\item
  follicular lymphoma
\item
  diffuse large-cell lymphoma
\item
  mantle cell lymphoma
\item
  Burkitt lymphoma
\item
  Extranodal Marginal Zone Lymphoma
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{临床表现}
\protect\hypertarget{ux4e34ux5e8aux8868ux73b0-9}{}
\begin{itemize}
\item
  painless peripheral lymphadenopathy + extra-lymphatic involve
\item
  ``B'' symptoms (fevers, night sweats, weight loss)
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Follicular Lymphoma 40\%}
\protect\hypertarget{follicular-lymphoma-40}{}
\begin{itemize}
\item
  (14;18) translocation that fuses the BCL2 gene and the IgH
\item
  ``overexpression'' of BCL2 protein
\item
  B cell markers such as CD20 and the germinal center B cell markers
  CD10 and BCL6
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Mantle Cell Lymphoma}
\protect\hypertarget{mantle-cell-lymphoma}{}
\begin{itemize}
\item
  (11;14) translocation that fuses the cyclin D1 gene to the IgH locu
\item
  overexpression of cyclin D1
\item
  cells express surface IgM and IgD, the B cell antigen CD20, and CD5,
  and contain high levels of cyclin D1 protein.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Extranodal Marginal Zone Lymphoma}
\protect\hypertarget{extranodal-marginal-zone-lymphoma}{}
\begin{itemize}
\item
  sustained by chronic inflammation
\item
  mature B cells expressing CD20 and surface immunoglobulin, usually IgM
\item
  cured by simple excision followed by radiotherapy
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Diffuse Large B Cell Lymphoma 35\%}
\protect\hypertarget{diffuse-large-b-cell-lymphoma-35}{}
\begin{itemize}
\item
  BCL6 is a transcription factor that is required for the generation of
  germinal center B cells
\item
  increased levels of BCL6 protein
\item
  (14;18) translocation involving the BCL2 gene that results in
  overexpression of BCL2 protein
\item
  EBV；human herpesvirus type 8 (HHV-8)
\item
  express the B cell antigen CD20. Many also express surface IgM and/or
  IgG. Other antigens (e.g., CD10, BCL2)
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Burkitt Lymphoma}
\protect\hypertarget{burkitt-lymphoma}{}
\begin{itemize}
\item
  translocations involving the MYC gene on chromosome 8 that result in
  overexpression of the MYC transcription factor.
\item
  express surface IgM,the B cell marker CD20, and the germinal center B
  cell markers CD10 and BCL6.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-10}{}
■ Treatment is based on histopathologic classification rather than on
stage

and consists of radiation, chemotherapy, or both.

■ Low-grade indolent NHL treatment is generally palliative. stage
\textless3 radiation

■ High-grade aggressive NHL treatment is aggressive chemotherapy with a
curative approach. A common regimen is rituximab, cyclophosphamide,
doxorubicin阿霉素, vincristine, and prednisone (R CHOP) + loco-region
radiation
\end{block}
\end{frame}

\begin{frame}
\begin{block}{Hodgkin lymphoma (HL)}
\protect\hypertarget{hodgkin-lymphoma-hl}{}
\begin{itemize}
\tightlist
\item
  Definition: A malignant lymphoma arising from germinal center B cells.
  It is characterized by the presence of multinucleated giant cells
  called Reed-Sternberg (RS) within a mixed inflammatory infiltrate.
\end{itemize}

\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208042227306.png}
\end{block}
\end{frame}

\begin{frame}
Bimodal age distribution in HL

\begin{enumerate}
[a.]
\item
  First large peak is 15 to 34 years old.
\item
  Second smaller peak is \textgreater50 years old.
\item
  Overall, tends to occur at younger ages than NHL
\end{enumerate}
\end{frame}

\begin{frame}
\begin{enumerate}
\tightlist
\item
  Activation of the transcription factor NF-κB (nuclear factor
  kappa-light-chain-enhancer of activated B cells) is common in
  classical HL.
\end{enumerate}

\begin{enumerate}
[a.]
\item
  NF-κB is activated by EBV or other factors.
\item
  When activated, it turns on genes that promote proliferation of B
  cells.
\end{enumerate}
\end{frame}

\begin{frame}
临床表现与分期

\begin{itemize}
\item
  B 症状
\item
  pel-ebstein fever (1-2w alternating btw high fever and normal)
\item
  分期
\end{itemize}

\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208042232740.png}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-11}{}
■ Treatment is stage-dependent, involving chemotherapy and/or radiation
(in early stage disease).

■ localized Dis (stage 1A,2A) radiation lymph node+ next contiguous
region

■ Dis \textgreater{} stage 3+B symptoms chemotherapy regimen is
Adriamycin

(doxorubicin), bleomycin, vinblastine, dacarbazine 氮烯唑胺(ABVD).
\end{block}
\end{frame}

\begin{frame}
\begin{block}{多发性骨髓瘤}
\protect\hypertarget{ux591aux53d1ux6027ux9aa8ux9ad3ux7624}{}
\begin{itemize}
\item
  Definition: Characterized by a clonal proliferation of malignant
  plasma cells in the BM and associated with a monoclonal protein in the
  bowel and urine
\item
  M-spike in a SPE occurs in 80\% to 90\% of cases ,Serum M protein is
  \textgreater3g/dL.
\end{itemize}

\includegraphics{https://gitee.com/rainoffallingstar/rainoffallingstar/raw/mydraft/_imgbed/202208042237779.png}

\begin{itemize}
\tightlist
\item
  Urinalysis for BJ protein is positive in 60\% to 80\% of cases.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}
\begin{itemize}
\item
  chromosomal translocations that fuse the IgH locus on chromosome 14 to
  oncogenes such as the cyclin D1 and cyclin D3 genes.
\item
  also supported by the cytokine interleukin 6 (IL-6), produced by
  fibroblasts and macrophages in the bone marrow stroma
\item
  translocations involving MYC
\end{itemize}
\end{frame}

\begin{frame}
\begin{itemize}
\item
  myeloma-derived factors upregulate the expression of the receptor
  activator of NF-κBligand (RANKL) by bone marrow stromal cells, which
  in turn activate osteoclasts
\item
  hypercalcemia and pathologic fractures.
\item
  dehydration and renal stones, and frequent bouts of bacterial
  pyelonephritis
\item
  elevated levels of immunoglobulin owing to the presence of an M
  protein
\item
  Bence Jones proteins , Tamm-Horsfall protein, and albumin.Light chain
  deposition in the glomeruli or the interstitium, either as amyloid or
  linear deposits, also may contribute to renal damage.
\end{itemize}
\end{frame}

\begin{frame}
\begin{block}{Diagnosis}
\protect\hypertarget{diagnosis-4}{}
■ Best initial test: Serum protein electrophoresis showing IgG or IgA
mono-

clonal spikes (see Figure 2.7-18).

■ Most accurate test: Bone marrow biopsy showing \textgreater{} 10\%
monoclonal

CD138+ plasma cells.
\end{block}
\end{frame}

\begin{frame}
\begin{block}{治疗}
\protect\hypertarget{ux6cbbux7597-12}{}
■ Patients \textless{} 70 years of age can be treated with chemotherapy
VRd: bortezomib硼替佐米,lenalidomide,and low-dose dexamethasone and
autolo-

gous bone marrow transplant(MDR gene).

■ Patients \textgreater{} 70 years of age are treated with melphalan and
prednisone.
\end{block}
\end{frame}

\begin{frame}
\begin{block}{the end of everything}
\protect\hypertarget{the-end-of-everything}{}
\end{block}
\end{frame}

\begin{frame}
\begin{block}{参考文献}
\protect\hypertarget{ux53c2ux8003ux6587ux732e}{}
\begin{columns}[T]
\begin{column}{0.5\textwidth}
\begin{enumerate}
\item
  the developing human
\item
  Robbins basic pathology
\item
  usmle step 2 first aid ck
\item
  usmle step 1 first aid
\item
  Yale-G First aid step 2\&3
\item
  hematology at a glance
\end{enumerate}
\end{column}

\begin{column}{0.5\textwidth}
\begin{enumerate}
\setcounter{enumi}{7}
\item
  usmle step 1 lecture notes
\item
  gojian's rapid review pathology
\item
  MD anderson mannul of oncology
\item
  pthoma foudation of pathoogy
\item
  wikipedia
\item
  pubchem
\item
  pubpath
\end{enumerate}
\end{column}
\end{columns}
\end{block}
\end{frame}

\begin{frame}
\end{frame}

\end{document}
